Today: 5 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight

Boeing stock price dips despite Ethiopian Dreamliner order as BA heads into earnings spotlight

New York, January 20, 2026, 14:48 EST — Regular session Boeing shares slipped slightly Tuesday after Ethiopian Airlines placed an order for nine 787-9 Dreamliners and finalized the purchase of 11 737 MAX jets, the companies confirmed. The stock traded around $247.13 in the afternoon, down about 0.2%, after fluctuating between $240.08 and $248.43. Ethiopian Airlines Group CEO Mesfin Tasew said, “We will continue to acquire more aircraft and adopt the latest technologies as part of our strategic vision to advance sustainable aviation.”
Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

Pfizer stock slips today as $1.9 billion ViiV exit and Novavax Matrix‑M deal land

New York, January 20, 2026, 14:46 EST — During the regular session Pfizer shares slipped 0.7% to $25.47 Tuesday afternoon, after GSK and Shionogi announced Pfizer will exit HIV-focused ViiV Healthcare in a $1.9 billion deal. Pfizer is set to get $1.88 billion for its 11.7% stake, with the deal expected to close in Q1 pending regulatory approval. That day, the stock fluctuated between $25.11 and $25.65. ViiV chair David Redfern called the move a way to “simplify the shareholder structure.” Pfizer has also cautioned investors that 2026 could be challenging, as COVID-19 product sales decline, pricing pressures mount, and key patents expire.
Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

Verizon stock price ticks higher as Frontier deal closes; what VZ investors watch next

NEW YORK, Jan 20, 2026, 14:48 EST — Regular session By 2:48 p.m. EST Tuesday, Verizon Communications Inc shares had risen roughly 0.4% to $39.07, following the closing of its cash acquisition of Frontier Communications Parent, according to an SEC filing. AT&T shares slipped about 0.2%, while T-Mobile US dropped around 0.6%. Frontier shareholders will receive $38.50 per share in cash, the filing stated.
Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

Capital One stock slides nearly 4% as credit-card rate cap deadline weighs on lenders

New York, Jan 20, 2026, 14:15 EST — Regular session Capital One Financial shares dropped 3.7% to $230.18 in Tuesday afternoon trading, underperforming the S&P 500 banks index, which fell 1.2%. Investors are weighing whether the Trump administration will push forward with a proposed one-year, 10% cap on credit-card interest rates after the Jan. 20 deadline, amid doubts about enforcing it without Congress. “For now, it’s an overhang,” Brian Jacobsen, chief economic strategist at Annex Wealth Management, told Reuters. The American Bankers Association warned that up to 159 million cardholders could lose access. Meanwhile, TD Cowen anticipates a “political compromise” involving stripped-down low-rate cards and voluntary “Trump cards” as potential workarounds.
20 January 2026
Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

New York, January 20, 2026, 14:02 EST — Regular session Merck & Co shares held steady on Tuesday following news that the company's personalized cancer vaccine, developed with Moderna, continued to lower the risk of melanoma recurrence and death when used alongside Keytruda. By 2:02 p.m. EST, Merck was down just 0.01% at $108.82, with the stock fluctuating between $107.06 and $109.11.
Chevron stock steadies near $166 as Turkey exploration talks surface and Tengiz outage drags on

Chevron stock steadies near $166 as Turkey exploration talks surface and Tengiz outage drags on

New York, January 20, 2026, 13:56 — Regular session Chevron shares barely moved Tuesday afternoon following a report that Turkey’s state oil firm is negotiating with the U.S. giant on joint oil and gas exploration. The stock edged up 0.04% to $166.32, fluctuating between $164.44 and $167.45 earlier. Exxon Mobil gained 0.4%, while the SPDR S&P 500 ETF slipped about 1.8%.
20 January 2026
P&G stock rises as Wall Street slides on tariff fears; earnings next on deck

P&G stock rises as Wall Street slides on tariff fears; earnings next on deck

New York, Jan 20, 2026, 13:47 EST — Regular session Procter & Gamble shares climbed 1.4%, hitting $146.49 in afternoon trading, brushing off a broad selloff that dragged major U.S. indexes down over 1%. The drop came after President Donald Trump warned of new tariff threats. He announced a 10% tariff starting Feb. 1 on imports from eight European countries, set to jump to 25% by June 1 unless the U.S. strikes a deal to buy Greenland.
Gold price breaks $4,700 record on tariff fears, lifting GLD and gold miners

Gold price breaks $4,700 record on tariff fears, lifting GLD and gold miners

New York, January 20, 2026, 13:41 — Regular session Gold prices smashed through $4,700 an ounce on Tuesday, hitting fresh highs as investors sought safety amid fresh U.S. tariff threats against Europe. Spot gold climbed roughly 2% to $4,761.58 per ounce by 1:02 p.m. ET after reaching $4,763.07; U.S. February futures jumped 3.7% to $4,766.80. Silver briefly surged past $95. “Gold has surged deeper into uncharted territory as investors hedge against rising political risk,” said Fawad Razaqzada, market analyst at City Index and FOREX.com, noting the metal soared 64% in 2025 and has added another 10% this year.
20 January 2026
1 431 432 433 434 435 878

Stock Market Today

  • Kamigumi (TSE:9364) Unveils ¥15B Buyback After Rough Quarter, P/E Still High
    July 5, 2026, 12:22 AM EDT. Kamigumi (TSE:9364) signed off on a share buyback worth up to ¥15 billion, or 4.25% of shares, following uneven trading. Shares are up 9.42% for the past week but down 5.03% over 90 days. The stock trades at a P/E of 16.5x, above the sector and the estimated fair P/E of 13x. That leaves Kamigumi possibly overvalued. Earnings grew 8.8% a year for five years, though consensus sees them slipping a bit over the next three years. A DCF model now values the stock just 1.9% over its buy price, showing only a small premium. Investors need to weigh if the buyback is enough, given the price and an uncertain outlook for earnings.
Go toTop